The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

President Trump's trade policies are sending many stocks that were performing well in the wrong direction and exacerbating ...

Novavax NVAX shares soared 11.4% in the last trading session to close at $6.24. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

The delay follows leadership changes within the FDA. Dr. Scott Steele has been appointed acting director of the agency’s ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a ...

Kennedy, a well-known vaccine skeptic, last week announced plans to reshape federal public health agencies, including cutting ...

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

A fake CDC-style vaccine page was removed after order from RFK Jr. The site was linked to Children’s Health Defense, an anti-vaccine group Kennedy founded The page included false claims linking ...